CorVel (NASDAQ:CRVL – Get Free Report) issued its quarterly earnings data on Tuesday. The business services provider reported $0.46 earnings per share for the quarter, Zacks reports. CorVel had a return on equity of 31.73% and a net margin of 9.64%.
CorVel Price Performance
NASDAQ CRVL traded down $2.53 during trading on Thursday, hitting $125.93. The company’s stock had a trading volume of 6,832 shares, compared to its average volume of 104,312. The company has a market cap of $6.42 billion, a PE ratio of 80.21 and a beta of 1.16. The business’s 50 day simple moving average is $123.83 and its 200-day simple moving average is $112.27. CorVel has a fifty-two week low of $76.20 and a fifty-two week high of $128.61.
Insider Transactions at CorVel
In related news, EVP Mark E. Bertels sold 1,050 shares of CorVel stock in a transaction that occurred on Thursday, December 5th. The stock was sold at an average price of $119.12, for a total transaction of $125,072.50. Following the completion of the transaction, the executive vice president now directly owns 2,580 shares in the company, valued at approximately $307,321. This trade represents a 28.93 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Company insiders own 47.57% of the company’s stock.
Analyst Upgrades and Downgrades
View Our Latest Stock Report on CorVel
CorVel Company Profile
CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.
Further Reading
- Five stocks we like better than CorVel
- The Basics of Support and Resistance
- Price Plunge in Roblox Presents Opportunity for Robust Gains
- Financial Services Stocks Investing
- Billions in Buybacks: 4 Stocks Rewarding Shareholders Now
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3 Steel Stocks to Gain Strength as Tariffs Reshape the Market
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.